STOCK TITAN

Oracle Corp SEC Filings

ORCL NYSE

Welcome to our dedicated page for Oracle SEC filings (Ticker: ORCL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Searching Oracle’s 300-page disclosures for a simple answer—like how much cloud services & license support revenue grew—can take hours. Add in multiple segments, Autonomous Database metrics, and intricate share-repurchase notes, and Oracle’s SEC filings quickly become a maze for even seasoned analysts.

Stock Titan solves that problem in one place. Our AI reads every Oracle quarterly earnings report 10-Q filing, Oracle annual report 10-K simplified, and Oracle 8-K material events explained the moment they hit EDGAR, then delivers plain-English summaries, red-flag alerts, and context. Need Oracle insider trading Form 4 transactions? You’ll see Oracle Form 4 insider transactions real-time—with visualized buy/sell trends—before the market reacts. Wondering about Oracle proxy statement executive compensation? Our platform highlights CEO pay, option grants, and performance triggers in seconds.

Here’s how professionals use the page:

  • Track Oracle executive stock transactions Form 4 to gauge insider sentiment.
  • Compare cloud revenue and license margins across periods without opening spreadsheets.
  • Export AI-curated key points from each Oracle earnings report filing analysis for quick stakeholder briefs.
  • Receive push alerts when a new 8-K details major OCI outages or acquisition announcements.

Whether you’re understanding Oracle SEC documents with AI for the first time or you need granular footnote data fast, Stock Titan’s real-time updates and expert layer of interpretation turn complex Oracle paperwork into actionable insight.

Filing
Rhea-AI Summary

Oracle Corporation (NYSE: ORCL) filed a Form 25 with the U.S. Securities and Exchange Commission to remove its 3.125% Notes due 2025 from listing and registration on the New York Stock Exchange (NYSE) under Section 12(b) of the Exchange Act. The filing, dated 10 July 2025 and signed by NYSE representative Anthony Sozzi, certifies that the Exchange has satisfied all applicable rules for delisting. The company may also have met the voluntary withdrawal requirements under Rule 12d2-2(c); however, no additional financial or strategic rationale is provided within the document.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.96%
Tags
insider
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.99%
Tags
current report
Filing
Rhea-AI Summary

Oracle CEO Safra Catz filed Form 144 indicating a proposed sale of 1,260,508 shares of common stock with an aggregate market value of $267.2 million. The shares were acquired through stock options exercise on June 27, 2025, and are planned to be sold through Fidelity Brokerage Services on the NYSE.

The filing reveals significant recent selling activity by Catz in the past week:

  • June 20: 2,284,371 shares for $474.2M
  • June 23: 1,410,547 shares for $289.8M
  • June 25: 1,873,791 shares for $397.8M
  • June 26: 1,865,701 shares for $396.9M

The sales are being executed under a 10b5-1 trading plan adopted on September 25, 2024. The shares are being sold from the Harbor Island Joint Rev Trust. Oracle's total shares outstanding are approximately 2.81 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Oracle (NYSE:ORCL) filed a Form 4 disclosing CEO Safra Catz’s cashless option exercises and same-day sales on 25-26 Jun 2025.

  • Options exercised: 3.74 M shares at $51.13; 5 M new performance-based options granted 24 Jun 2025.
  • Shares sold: 3.74 M shares at weighted-average prices of $210.64-$215.44, realising ≈$793 M.
  • Post-transaction ownership: 1,118,592 directly-held shares (unchanged) plus 1.26 M unexercised options.

The sizeable monetisation, though executed under a Rule 10b5-1 plan, may influence investor sentiment and raises governance questions about pay design.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
insider
-
Rhea-AI Summary

Larry Ellison, Oracle's Executive Chairman, Chief Technology Officer, and 10% owner, received a significant stock option grant on June 24, 2025. The Form 4 filing discloses the acquisition of 5,000,000 stock options with the following key details:

  • Exercise price set at $51.13 per share
  • Options become exercisable on June 24, 2025
  • Expiration date is July 20, 2025
  • Represents 2/7 of shares from a performance-based option that vested upon Compensation Committee certification

This transaction indicates a significant performance-based compensation award for Ellison, who holds multiple leadership roles at Oracle. The short exercise window (approximately one month) and the performance-based vesting conditions suggest this is part of a structured executive compensation plan tied to specific company goals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
insider
Filing
Rhea-AI Summary

Oracle CEO Safra Catz Files Form 144 for Significant Stock Sale

Oracle CEO Safra Catz has filed a Form 144 notice indicating plans to sell 1,865,701 shares of Oracle common stock with an aggregate market value of $396.85 million. The shares were acquired through stock options exercise on June 26, 2025, and are planned to be sold via Fidelity Brokerage Services on the NYSE.

Notable recent trading activity by Catz in the past 3 months includes:

  • June 20, 2025: Sold 2,284,371 shares for $474.22 million
  • June 23, 2025: Sold 1,410,547 shares for $289.79 million
  • June 25, 2025: Sold 1,873,791 shares for $397.78 million

The shares are being sold from the Harbor Island Joint Rev Trust. The sale follows a Rule 10b5-1 trading plan adopted on September 25, 2024. Oracle's total shares outstanding stand at 2.81 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
other

FAQ

What is the current stock price of Oracle (ORCL)?

The current stock price of Oracle (ORCL) is $235.41 as of August 25, 2025.

What is the market cap of Oracle (ORCL)?

The market cap of Oracle (ORCL) is approximately 663.9B.
Oracle Corp

NYSE:ORCL

ORCL Rankings

ORCL Stock Data

663.92B
1.64B
41.55%
45.18%
0.74%
Software - Infrastructure
Services-prepackaged Software
Link
United States
AUSTIN